Tresiba FlexTouch 100 E/ml, Injektionslösung

7680625630016 CH-62563 Injektionslösung

Associated product:

TRESIBA FlexTouch 100 U/ml 5 stylo pré 3 ml
Tresiba FlexTouch 100 E/ml, Injektionslösung
Tresiba FlexTouch 100 E/ml, Injektionslösung
Tresiba FlexTouch 100 E/ml, Injektionslösung
1 / 3
google

Article details

Package size
5 x 3
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/05/2025
Patient information leaflet
Français
13/05/2025
Patient information leaflet
Italien
13/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
600.0 NMOL Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 105.15
Specialties list
Yes
Generic
No
SL addition date: 01/06/2013

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
62563
Drug name
Tresiba FlexTouch, Injektionslösung
Galenic form
INLFP
ATC Code
A10AE06
Authorization status
Z
Dispensing category
B
First authorization
12/03/2013
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
TRESIBA FlexTouch 100 U/ml 5 stylo pré 3 ml
Description (DE)
TRESIBA FlexTouch 100 E/ml 5 Fertpen 3 ml
Market launch
12/03/2013
Narcotic (BTM)
No

Other package sizes (3)

None
None None
GTIN: None
Not in V1
TRESIBA FlexTouch 200 U/ml 3 stylo pré 3 ml
3 x 3 ML
GTIN: 7680625630023
View
None
None None
GTIN: None
Not in V1